Blind mole rats have degenerated subcutaneous eyes that are visually nonfunctional. In this investigation, we have compared the tissue specificity of the small heat shock protein (shsp)͞␣B-crystallin promoter of the mole rat superspecies, Spalax ehrenbergi, with that of the mouse. Earlier experiments showed that mouse shsp͞ ␣B-crystallin promoter͞enhancer activity is high in the lens and moderate in the heart and skeletal muscle of transgenic mice. Here, we show in transgenic mouse experiments using the firefly luciferase reporter gene that, despite relatively few changes in sequence, the mole rat shsp͞␣B-crystallin promoter͞enhancer has selectively lost lens activity after 13.5 days of embryogenesis (E13.5). The ratios of mole rat͞mouse promoter activity were 0.01 for lens, 1.7 for heart, and 13.6 for skeletal muscle in 8-wk-old transgenic mice. Our data indicate that the shsp͞␣B-crystallin promoter͞enhancer has undergone adaptive changes corresponding to the subterranean evolution of the blind mole rat. We speculate that selective pressures on metabolic economy may have contributed to these tissue-specific modifications of promoter͞ enhancer function during adaptation to life underground.
A lthough the eyes of the adult blind mole rat are severely regressed (see Fig. 1 ), the early embryo develops an optic cup and lens vesicle comparable to that of an embryonic day 10 (E10) mouse eye (1, 2) . Further lens development is associated with abnormal primary fiber cell elongation, the appearance of vacuolar spaces, vascularization, and the eventual shriveling of the lens. In addition to the degenerated lens, a hypertrophied and pigmented iris-ciliary body fills the anterior chamber, the optic fissure does not close, and the anterior chamber collapses. The minute, regressed mole rat adult eye, embedded beneath the skin, retains a neuroretina and reduced optic nerve, although retinal projections to thalamic and tectal structures involved in visual perception are reduced by more than 90% (3) .
The diverse crystallins comprise 80-90% of the soluble protein of vertebrate lenses (4) (5) (6) . The ubiquitous crystallins (the ␣-and the ␤͞␥-crystallins) are represented in all vertebrate lenses whereas the taxon-specific crystallins (also called enzymecrystallins because they are identical to or derived from metabolic enzymes) are limited to selected species (4, 7) . The two ␣-crystallins (␣A and ␣B) originated by duplication of an ancestral small heat shock protein (shsp) gene (5, 6) . ␣A-Crystallin has specialized for lens expression; by contrast, shsp͞ ␣B-crystallin has remained a functional, stress-inducible shsp (4, 5, 8, 9) , although it is highly expressed in the lens and to a lesser extent in many other tissues, especially the heart and skeletal muscle (7, 10) . Indeed, shsp͞␣B-crystallin expression commences in the embryonic heart before eye development and in the eye during lens induction (11, 12) . Mutations in the human shsp͞␣B-crystallin gene (CRYAB) cause desmin-related myopathy (13) and dominant congenital posterior polar cataracts (14) . In addition, shsp͞␣B-crystallin is up-regulated in human brain tumors and numerous neurodegenerative diseases including Alexander's disease, Alzheimer's disease, Creutzfeldt-Jakob disease, Parkinson's disease, and multiple sclerosis, among others (9, 15) . Although ␣A-crystallin knockout mice develop lens opacification (16) , shsp͞␣B-crystallin null mice appear to have normal lenses but show various signs of muscle degeneration (17) . The lens opacification of the ␣A-crystallin knockout mice is likely because of the formation of inclusion bodies in the lens composed mainly of shsp͞␣B-crystallin (16) .
Regulatory elements of the mouse ␣B-crystallin gene that control its expression in the lens, heart, and skeletal muscle have been identified. The lens-specific regulatory (LSR) regions [Ϫ147͞Ϫ118 (LSR1) and Ϫ78͞Ϫ48 (LSR2)] within the Ϫ164͞ ϩ43 proximal promoter can drive lens expression of a reporter gene in transgenic mice (18, 19) . LSR1 and LSR2 are transactivated by Pax-6 and retinoic acid receptors (20) (21) (22) . The Ϫ427͞ Ϫ258 enhancer of the mouse shsp͞␣B-crystallin gene contains at least five regulatory regions that are necessary for expression in skeletal muscle and heart (20, 23, 24) . Deletion of this enhancer region also reduces but does not eliminate promoter activity in the lens of transgenic mice (18, 19) .
Few studies have explored possible changes in gene expression during eye regression. Despite that the mole rat ␣A-crystallin cDNA has undergone numerous mutations, consistent with its lack of use as a crystallin in the degenerated lens of this species (25) , the sequence of the mole rat ␣A-crystallin promoter is surprisingly similar to that of the mouse (9, 25) . The ␣A-crystallin promoter sequence of the blind cavefish is also highly similar to the mouse despite that the gene is not expressed in the lens (26) . It is not known yet whether the mole rat or blind cavefish ␣A-crystallin promoter can drive a reporter gene in the lens of transgenic mice. In the present study, we have explored the mole rat shsp͞␣B-crystallin promoter͞enhancer in transgenic mice to test the possibility that lens-specific activity has been down-regulated along with adaptive changes associated with subterranean evolution.
Materials and Methods
Immunohistochemistry of Mouse and Spalax Eyes. Ten-micrometer eye sections from newborn mole rats Spalax carmeli, diploid chromosome number 2n ϭ 58, from Haifa, and adult mole rats, Spalax judaei, 2n ϭ 60, from Anza, Samaria, both species belonging to the Spalax ehrenbergi superspecies in Israel (27) , were deparaffinized, hydrated, postfixed, and treated for endogenous peroxidases as described previously (28) . Immunostaining was performed overnight at 4°C with either a rabbit anti-mouse ␣-crystallin antibody or a rabbit anti-mouse ␥-crystallin antibody (both provided by D. Carpenter, National Eye Institute, Bethesda, MD) at a 1:4,000 dilution. Adult mouse lens sections were used as positive controls for the antibodies. The primary antibody was omitted to serve as a negative control. The sections were incubated with biotinylated Ig and avidin-biotinhorseradish peroxidase complex (Vectastain Elite ABC Kit, Vector Laboratories) according to the manufacturer's instructions. Immunoreactivity was visualized with diaminobenzidine (Vector Laboratories). Slides were washed under running tap water to terminate the color-producing reaction and mounted by using Aqua Poly͞Mount (Polysciences).
SDS͞PAGE of Proteins of Newborn and Adult Mole Rat Eyes.
Newborn and adult mole rat eyes were homogenized in PBS at pH 7.0 and then centrifuged at 15,000 ϫ g for 15 min. The supernatant was saved as the soluble fraction. The pellet was washed twice with PBS buffer and redissolved in 1% SDS as the insoluble fraction. Samples were examined by 12.5% SDS͞PAGE; the gel was stained with Coomassie brilliant blue R-250 staining solution (Bio-Rad) and destained with 5% methanol, 7.5% acetic acid destaining solution.
Isolation of the shsp͞␣B-Crystallin Promoter from S. ehrenbergi. The nucleotide region (Ϫ943͞ϩ45) of the mole rat shsp͞␣B-crystallin gene (GenBank accession no. AJ427968) was cloned from two species: Spalax galili (2n ϭ 52, Kerem Ben-Zimra population) and S. judaei (2n ϭ 60, Anza population) (27) . The region was cloned by employing PCR using a 5Ј primer (5Ј-GTC(T͞G)ACACCACCCAAAATAGTGC-3Ј) derived from the human shsp͞␣B-crystallin gene (GenBank accession number M28638) and a 3Ј primer (5Ј-GGATCCAGGGGTGGTGGAT-GGCG-3Ј) derived from the mole rat shsp͞␣B-crystallin gene (GenBank accession number AJ293658).
Construction of Mole Rat and Mouse shsp͞␣B-Crystallin Promoter
Constructs. The Ϫ668͞ϩ45 mole rat promoter fragment was amplified by PCR using Pfu polymerase (Stratagene). The primers used for the mole rat amplification (5Ј-GGGGTAC-CAAGGAGGGGCCTAGTTGAGAC-3Ј and 5Ј-TCCCCCCG-GGTGGATGGCGATGTCCA-3Ј) generated an amplicon with a Kpn⌱ site at the 5Ј end and an Xma⌱ site at the 3Ј end. The amplicon was inserted into the multiple cloning region of the pGL3-Basic luciferase reporter plasmid (Promega). The Ϫ661͞ ϩ43 promoter fragment of the mouse shsp͞␣B-crystallin gene was excised from pD96 (7) by using BamH⌱ and inserted into the Bgl⌱⌱ site in the multiple cloning region of the pGL3-Basic plasmid. Cell Culture and Transient Transfections. N͞N1003A rabbit lens cell line, ␣TN4-1 mouse lens cell line, and C2C12 myoblast cell line were cultured as described previously (23) . The cells were cotransfected with 1 g of either mole rat or mouse promoter luciferase reporter plasmid and 100 ng of pRL-SV40 Renilla luciferase vector (Promega) by incubation with Fugene reagent (Roche Molecular Biochemicals) for 48 h. Cells were treated with a cell lysis solution and frozen at Ϫ80°C. Luciferase assays were performed by using the Dual Reporter Luciferase Assay Kit (Promega) and Monolight Luminometer (Analytical Luminescence Laboratory, Sparks, MD).
Transgenic Mice and Luciferase Assays. Kpn⌱-Sal⌱ (2.8-kb) fragments containing either the mouse or mole rat shsp͞␣B-crystallin promoter fused to the firefly luciferase gene were isolated from their respective plasmids, purified from an agarose gel by using the Geneclean kit (Bio 101), and injected into the pronucleus of a single-celled mouse embryo (FVB͞N strain) obtained from superovulated FVB͞N females. Injected embryos were transferred into CD1 females. Tissues from transgenic mice were homogenized in lysis buffer by using the luciferase assay system (Promega). Samples were centrifuged at top speed in a microcentrifuge, and firefly luciferase activity of the supernatant fraction was measured by using the Luciferase Assay System (Promega) and the TR717 Microplate Luminometer (Applied Biosystems). The concentration of soluble protein was determined by using the Bio-Rad Protein Assay.
Results

␣-
Crystallins have been observed previously in lenses of the mole rat, S. ehrenbergi, by immunofluorescence (29) . In addition, mole rat shsp͞␣B-crystallin, which is 90% identical to that of other mammals, has been detected in the eye and other tissues by reverse transcription-PCR (30) . Here, we confirm ␣-crystallin expression in the degenerated newborn Spalax lens by immunocytochemistry (Fig. 1a) . Omission of the primary antibody gave negative results, indicating specificity of the ␣-crystallin antibody in the mole rat lens. We did not observe expression of ␥-crystallin in the Spalax lens (Fig. 1a) . Furthermore, separate SDS͞ PAGE of the mole rat eye showed that all crystallins, including shsp͞␣B-crystallin, are barely detectable at birth or in the adult (Fig. 1b) . The actual levels of crystallins within the shriveled mole rat lens cannot be determined because it requires isolation of the minute degenerate lens within the small eye. Nonetheless, although our immunocytochemical results did not distinguish ␣A-and ␣B-crystallin, we conclude that shsp͞␣B-crystallin expression is, at best, relatively low in the lens of the mole rat.
To study promoter structure and function of mole rat shsp͞ ␣B-crystallin, we isolated the upstream region of shsp͞␣B-crystallin gene from two different mole rat species, S. galili and S. judaei (27) . The Ϫ681͞ϩ64 sequences of the shsp͞␣B-crystallin gene from these mole rats have only two nucleotide differences (data not shown). The S. galili shsp͞␣B-crystallin upstream sequence is 82%, 83%, and 78% identical to that of the rat, mouse, and human, respectively (Fig. 2) . The similarity of the mole rat sequence with the rodent and human sequences, despite rodents and humans having diverged approximately 110 million years ago (31) , suggests functional conservation. The sequence similarity is particularly striking in the lens enhancer elements LSR1 and LSR2 within the Ϫ164͞ϩ43 proximal promoter (18, 20) as well as in the Ϫ427͞Ϫ258 muscle-preferred enhancer of the mouse gene (20, 23) , consistent with the conservation of gene regulation.
The S. galili Ϫ668͞ϩ43 promoter fragment was subcloned into the pGL3 firefly luciferase expression vector to compare its activity with the corresponding Ϫ661͞ϩ43 mouse promoter fragment, shown earlier to be highly active in lens, skeletal muscle, and heart of transgenic mice (7). In transient transfec- tions, the mouse construct was 2.4 and 5 times more active than the Spalax promoter in N͞N1003A rabbit lens cells and ␣TN-4 mouse lens cells, respectively (Fig. 3) . By contrast, the mouse construct was only 1.7 times more active than the mole rat promoter in transiently transfected C2C12 mouse myoblasts. The reduced activity of the mole rat promoter in the transfected lens cell lines may be a result of the same changes in transcriptional regulation of shsp͞␣B-crystallin that cause a reduction of expression in the Spalax eye. To investigate this reduction in promoter activity further, we made transgenic mice with the mole rat promoter construct.
Transgenic mice were made by using the mole rat and mouse shsp͞␣B-crystallin promoter:luciferase constructs as transgenes, and luciferase activity was determined in different tissues of the 8-wk-old F 1 progeny. As expected (18, 32) , the highest average values for mouse shsp͞␣B-crystallin promoter activity were in the lens, heart, and skeletal muscle (gracius leg muscle) of the transgenic mice (Fig. 4a) . By contrast, the mole rat promoter showed little lens but high skeletal muscle and moderate heart activity in four lines of transgenic mice. The average luciferase activity found in the lens resulting from the mole rat shsp͞␣B-crystallin promoter was 77-fold lower than that resulting from the mouse promoter in the transgenic mice (Fig. 4b) . This finding was reversed in the muscle, where the mole rat shsp͞␣B-crystallin promoter was 13 times greater than the mouse promoter. The heart luciferase activity generated by the mole rat promoter was not statistically different from the activity generated by the mouse promoter in the transgenic mice (Fig. 4b) . The ratios of mole rat to mouse shsp͞␣B-crystallin promoter activity were 0.01, 1.7, and 13.6, respectively, in the transgenic mice (Fig. 4b ). There were also small elevations of luciferase activity in the cornea, lung, and testis of the transgenic mice containing the mole rat shsp͞␣B-crystallin promoter that did not occur in the mice containing the mouse promoter (data not shown). Near background levels of mouse and mole rat shsp͞␣B-crystallin promoter activity were found in the retina, brain, liver, spleen, kidney, and ovary of the transgenic mice (data not shown). Genomic Southern analyses indicated that copy numbers of the shsp͞␣B-crystallin promoter transgenes of the mouse (between 6 and 10 copies) and mole rat (between 2 and 10 copies) were similar.
Because the mole rat eye appears normal during early development (1, 2), we investigated whether the mole rat shsp͞␣B-crystallin promoter functions in the embryonic lens of the transgenic mice (Fig. 5) . The results showed higher mole rat shsp͞␣B-crystallin The highest activity using the mole rat construct (muscle) and the highest activity using the mouse construct (lens) were given a value of 100. Setting the mole rat muscle activity to 100 lowered the heart activity relative to the mouse even though the average luciferase activity of the mole rat construct was actually higher than that of the mouse. (b) Average relative luciferase units per g of soluble protein, with standard deviations of the lens, heart, and skeletal muscle in the transgenic mice. The differences in activity between the mole rat and the mouse promoters were statistically significant in the lens (P Ͻ 0.001) and in the muscle (P Ͻ 0.02), whereas in the heart the differences were not statistically significant. promoter activity in the lens of the 13.5-day-old transgenic mouse embryos than in the 8-wk-old mice (Fig. 5) . Separate whole mount in situ hybridization experiments also showed lens activity of the mole rat shsp͞␣B-crystallin promoter in E11.5 transgenic mice (data not shown). Lens activity of the mole rat promoter was virtually absent by E14.5, resembling its activity in the 8-wk-old adult lens (Fig. 5) . The mole rat shsp͞␣B-crystallin promoter was active in the heart at E13.5, E14.5, and E16.5 (Fig. 5) . In one test, muscle activity of the mole rat shsp͞␣B-crystallin promoter was Ϸ3 times greater at E14.5 than the activity of the mouse promoter (data not shown). Thus, there is a developmentally regulated loss of mole rat shsp͞␣B-crystallin promoter function specifically in the lens of transgenic mice after E13.5, a time that correlates well with the regression of the mole rat eye (1).
Discussion
Our transgenic mouse data suggest that the loss of mole rat shsp͞␣B-crystallin promoter activity in the lens is accompanied by an increase in promoter activity in the muscle. The relative decrease in mole rat shsp͞␣B-crystallin promoter activity in the lens was also evident in the transfected ␣TN4-1 and N͞N1003A lens cells, despite that the mole rat promoter activity was greater in the cultured cells than in the transgenic mice. The absence of an increase of the mole rat promoter activity in the transfected C2C12 muscle cells may be due to the fact that these were cultured myoblasts with nonintegrated plasmids rather than differentiated muscle with integrated transgenes as in transgenic mice.
The levels of endogenous shsp͞␣B-crystallin gene expression in the mole rat lens and muscle have not been determined. The former is complicated by the difficulty of isolating the degenerate mole rat lens. The reverse transcription-PCR data of Avivi et al. (30;  Fig. 3) showed that shsp͞␣B-crystallin gene expression occurs in the mole rat eye and, after normalization for the actin controls, suggest that shsp͞␣B-crystallin gene expression is indeed higher in skeletal muscle than in the eye and other tissues of the mole rat. Establishing the absolute level of shsp͞␣B-crystallin expression in the mole rat muscle is complicated by probable variations of shsp͞␣B-crystallin promoter activity with muscle type, with activity levels, and with age.
Our data showing that the loss of mole rat shsp͞␣B-crystallin promoter activity in the lens is accompanied by an increase in muscle promoter activity fits with the idea that tissue regression during evolution may be associated with compensating increases, or constructive modifications, in other modalities (2) . For example, mole rats have degenerated, subcutaneous eyes that are visually nonfunctional, but are engaged in circadian entrainment and have increases in retinal projections to structures involved in photoperiodic and photo-neuroendocrine regulation (1-3) . Moreover, the circadian rhythm transcription factor CLOCK of the blind mole rat has an expanded glutamine-rich domain that may cause a change in its transcriptional activity (33) . In addition, the rhodopsin gene of Spalax is functional in retinal cells despite the overall degenerate eye (34), as is true for melanopsin and pituitary adenylate cyclase-activating peptide (PACAP) (J. Hannibal, P. Hindersson, E.N., and J. Fahrenkrug, unpublished results). Blind cavefish, which also show eye regression, have constructive progression of larval jaws, maxillary teeth, taste buds, cranial neuromasts, and telencephalon (35) . Cavefish eye degeneration developed over a period of 10,000 to 1 million years (35) vs. the 30-40 million years since mole rats went underground (2) .
The relative increase in shsp͞␣B-crystallin promoter activity in the skeletal muscle of the blind mole rat may have an adaptive role. It seems reasonable to speculate that in the burrowing mole rat the need for shsp͞␣B-crystallin in muscle would be more adaptively useful than in the lens (2) . It is noteworthy that the mole rat muscle regulatory factor-binding (MRF) element (which is critical for muscle activity) of the shsp͞␣B-crystallin enhancer (23) has more differences than that of the other enhancer elements (see Fig. 2 ). Further experiments are required to determine whether the apparent adaptive increase in muscle activity of the mole rat promoter occurred independently from the loss in lens expression.
We do not know why the mole rat shsp͞␣B-crystallin promoter loses activity in the embryonic transgenic mouse lens. One possibility is that mouse shsp͞␣B-crystallin promoter activity undergoes a mechanistic switch after E13.5 that the mole rat promoter cannot accomplish, such as the binding of an additional transcription factor associated with lens fiber cell differentiation that is aberrant in the mole rat. Another possibility is that the mole rat promoter binds a repressor in the mouse lens after E13.5. In this connection, experiments in our laboratory have revealed the presence of an insulator and putative repressor between the mouse shsp͞␣B-crystallin enhancer and the MKBP͞HSPBP2 gene located Ϸ1 kb upstream of the shsp͞␣B-crystallin gene (S. Swamynathan and J.P., unpublished results).
Although the mechanism of eye regression in the mole rat is not known, it is of interest that a reduced domain of Pax-6 expression during the formation of the optic primordia may contribute to the eye degeneration of cavefish (35) . By analogy, a Pax-6 involvement in degeneration of the mole rat eye would be consistent with the present lens-specific loss of shsp͞␣B-crystallin promoter activity because the shsp͞␣B-crystallin promoter binds and is activated by Pax-6 (21). In any case, the selective loss of the mole rat shsp͞␣B-crystallin promoter activity in the lens of transgenic mice was surprising in view of its sequence similarity with the mouse promoter. It appears that minor sequence modifications, presumably associated with adaptation to life underground, can be associated with profound changes in promoter activity. These adaptive evolutionary changes may economize metabolic expenses (2, 3) , by limiting expression of shsp͞␣B-crystallin in the degenerated lens and augmenting expression in the muscle, thereby increasing fitness.
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